Back to DIMENSIONAL FUND ADVISORS LP DIMENSIONAL FUND ADVISORS LP

TRDATRDA
8 quarters

Position history for DIMENSIONAL FUND ADVISORS LPDIMENSIONAL FUND ADVISORS LP's holdings in ENTRADA THERAPEUTICS INC

Yes. Dimensional Fund Advisors holds 376,136 shares of TRDA (Entrada Therapeutics), worth $2.8M, as of its Q2 2026 13F filing. It increased the position by 51,665 shares (+15.9%) from Q1 2026. Dimensional Fund Advisors has held TRDA since Q3 2024, across 8 quarterly 13F filings.

Current Value

$2.8M

Current Shares

376,136

Total Value Change

+$1.2M

Total Shares Change

+280,728

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
376,136
+15.9%
$2.8M0.0%$7.36
30
2026-Q1
Increased
324,471
+18.7%
$4.1M0.0%$11.85
31
2025-Q4
Decreased
273,378
-30.7%
$2.8M0.0%$10.09
0
2025-Q3
Decreased
394,279
-7.0%
$2.3M0.0%$5.84
0
2025-Q2
Increased
423,985
+29.6%
$2.8M0.0%$6.91
33
2025-Q1
Increased
327,127
+50.8%
$3M0.0%$9.56
37
2024-Q4
Increased
217,006
+127.5%
$3.8M0.0%$17.37
43
2024-Q3
New
95,408
-
$1.5M0.0%$16.45
35

Other major holders of TRDA: BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used